Naoumov, Nikolai V.
UCL Division of Medicine,
United Kingdom
2025 Rank: 76246
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Gastroenterology & Hepatology
SubField 2:
Virology
Rank in SubField 1: 1105 out of 108265 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 76246 | 81831 |
| Total Cites | 10001 | 11093 |
| H-index | 49 | 52 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 196 | 199 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 1061 | 1116 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 4255 | 4659 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8126 | 8718 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.27 |
| Self-Citation Percentage |
9.84%
|
|
Naoumov, Nikolai V.
Peking University First Hospital,
China
2024 Rank: 73115
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Gastroenterology & Hepatology
SubField 2:
Virology
Rank in SubField 1: 1071 out of 103730 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 73115 | 79067 |
| Total Cites | 9750 | 10805 |
| H-index | 48 | 50 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 185 | 188 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 1018 | 1066 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 4140 | 4531 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7913 | 8475 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.27 |
| Self-Citation Percentage |
9.76%
|
|
Naoumov, Nikolai V.
Novartis International AG,
Switzerland
2023 Rank: 69393
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Gastroenterology & Hepatology
SubField 2:
Virology
Rank in SubField 1: 1048 out of 98720 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69393 | 75283 |
| Total Cites | 9538 | 10584 |
| H-index | 47 | 50 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 178 | 181 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 978 | 1023 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 4025 | 4411 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7738 | 8291 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.28 |
| Self-Citation Percentage |
9.88%
|
|
Naoumov, Nikolai V.
Novartis International AG,
Switzerland
2022 Rank: 64348
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Gastroenterology & Hepatology
SubField 2:
Virology
Rank in SubField 1: 968 out of 95371 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64348 | 71394 |
| Total Cites | 9255 | 10273 |
| H-index | 47 | 48 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 164 | 167 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 950 | 995 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 3880 | 4252 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7494 | 8035 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.28 |
| Self-Citation Percentage |
9.91%
|
|
Naoumov, Nikolai V.
Novartis International AG,
Switzerland
2021 Rank: 61790
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Gastroenterology & Hepatology
SubField 2:
Virology
Rank in SubField 1: 929 out of 91513 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 61790 | 67842 |
| Total Cites | 9032 | 10016 |
| H-index | 46 | 48 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 161 | 164 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 934 | 978 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 3816 | 4181 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7304 | 7828 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.28 |
| Self-Citation Percentage |
9.82%
|
|
Naoumov, Nikolai V.
Novartis International AG,
Switzerland
2020 Rank: 55690
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Gastroenterology & Hepatology
SubField 2:
Virology
Rank in SubField 1: 864 out of 76367 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 55690 | 61703 |
| Total Cites | 8747 | 9703 |
| H-index | 46 | 48 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 153 | 156 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 918 | 962 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 3659 | 4013 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7073 | 7577 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.28 |
| Self-Citation Percentage |
9.85%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.